Related Experiment Video
Updated: Dec 29, 2025
07:32
Preparation and Characterization of Individual and Multi-drug Loaded Physically Entrapped Polymeric Micelles
Published on: August 28, 2015
11.8K
Reexamining the Academic Partnerships with Federal Pharmacy: 2018-19 Argus Commission Report.
Peggy Piascik1, Cynthia J Boyle2, Patricia Chase3
1University of Kentucky College of Pharmacy, Lexington, Kentucky, Chair.
American Journal of Pharmaceutical Education
|February 1, 2020
Summary
Progressive pharmacy patient care services are expanding within federal agencies. Pharmacy education programs should partner with federal leaders to enhance patient care for diverse populations.
Area of Science:
- Pharmacy Practice
- Public Health
- Healthcare Administration
Background:
- Progressive patient care services in pharmacy are increasingly important.
- Federal branches like the Veterans Administration and Department of Defense offer unique practice settings.
Purpose of the Study:
- To examine the history and current status of progressive pharmacy patient care services in federal agencies.
- To assess the involvement of pharmacy faculty, students, and residents in these practices.
- To identify opportunities for expanding learner placements in federal pharmacy settings.
Main Methods:
- A review of progressive pharmacy patient care services was conducted.
- The engagement of pharmacy learners (faculty, students, residents) was assessed.
- Analysis focused on practices within the Veterans Administration, Department of Defense, and U.S. Public Health Service.
Main Results:
- Progressive pharmacy patient care services are established across various federal branches.
- Pharmacy faculty, students, and residents are engaged in these progressive practices.
- There is a recognized need to expand learner opportunities in these settings.
Conclusions:
- Colleges and schools of pharmacy should advocate for increased learner placements in federal progressive practices.
- Collaboration between pharmacy education and federal pharmacy leaders is crucial.
- Partnerships can advance patient care, particularly for special populations in federal programs.
Related Concept Videos
01:17Healthcare Agencies II
972
There are various healthcare agencies in the United States—some of which are managed by religious institutions and others by different government branches.
Parish nursing is a growing specialty nursing profession that focuses on holistic healthcare, health promotion, and illness prevention. It blends professional nursing practice with a health ministry, focusing on health and healing within the context of a Christian community. Parish nurses serve as health educators, referral sources,...
Parish nursing is a growing specialty nursing profession that focuses on holistic healthcare, health promotion, and illness prevention. It blends professional nursing practice with a health ministry, focusing on health and healing within the context of a Christian community. Parish nurses serve as health educators, referral sources,...
972
01:27Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence
114
Changes in polymorphic forms can significantly influence the bioavailability of poorly soluble drugs. Although the FDA defines pharmaceutical equivalence based on having the same active ingredient, dosage form, and route of administration, it does not automatically disqualify products with different polymorphic forms. This means two products with different polymorphs can still be deemed pharmaceutically equivalent. However, polymorphic differences can affect properties like wettability,...
114
01:26FDA Approved Drugs: Changes to Approved Drugs
152
Post-approval, manufacturers may modify an approved new or generic drug product. Such modifications can encompass alterations in the Active Pharmaceutical Ingredient (API), manufacturing process, formulation, batch size, manufacturing site, and container closure system (FDA Guidance for Industry, April 2004). Often, a drug product may undergo multiple changes.These modifications require careful evaluation to determine their potential impact on the drug product's identity, strength, quality,...
152
01:24Dosage Regimen: Individualization
124
Individualization in dosing regimens is the customization of medication doses for individual patients. Its necessity arises from the goal of maximizing therapeutic benefits while minimizing risks. This approach is pivotal because human responses to drugs can vary widely; what is effective for one person may be inadequate or excessive for another. Interpatient (intersubject) variability refers to differences in drug responses between individuals, while intrapatient (intrasubject) variability...
124
01:26Pharmaceutical Equivalents
148
As defined by regulatory standards, pharmaceutical equivalents require generic drug products to have identical dosage forms and chemically identical active pharmaceutical ingredients (APIs). They must adhere to compendial or applicable standards for potency, content uniformity, disintegration times, and dissolution rates. In the case of modified-release dosage forms, variations in drug content are permissible as long as the delivered amount remains consistent with the innovator drug product.
148
01:19Pharmaceutical Alternatives: Excipients and Impurities-Related Therapeutic Nonequivalence
113
Pharmaceutical products contain more than just the active drug; they also contain various excipients such as binders, solubilizers, stabilizers, preservatives, and other elements. In some cases, impurities or contaminants might be present. Traditionally, quality control in pharmaceuticals has primarily focused on the analysis of the active drug, often overlooking the impact of these additional components. The recent issue with heparin contamination by over-sulfated chondroitin sulfate, a...
113